3.91
0.07 (1.82%)
| Penutupan Terdahulu | 3.84 |
| Buka | 3.87 |
| Jumlah Dagangan | 765,022 |
| Purata Dagangan (3B) | 650,857 |
| Modal Pasaran | 291,663,328 |
| Harga / Pendapatan (P/E TTM) | 26.07 |
| Harga / Jualan (P/S) | 1.29 |
| Harga / Buku (P/B) | 0.680 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 25 Feb 2025 - 3 Mar 2025 |
| Margin Keuntungan | 5.07% |
| Margin Operasi (TTM) | -14.15% |
| EPS Cair (TTM) | 0.150 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | -55.20% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 2.61% |
| Nisbah Semasa (MRQ) | 12.60 |
| Aliran Tunai Operasi (OCF TTM) | 68.63 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | 63.77 M |
| Pulangan Atas Aset (ROA TTM) | 0.71% |
| Pulangan Atas Ekuiti (ROE TTM) | 2.74% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Medical Instruments & Supplies (US) | Bercampur | Bercampur |
| Medical Instruments & Supplies (Global) | Bercampur | Bercampur | |
| Stok | OraSure Technologies, Inc. | Menurun | Menurun |
AISkor Stockmoo
| Konsensus Penganalisis | -2.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | -2.0 |
| Purata Bergerak Teknikal | 0.0 |
| Osilator Teknikal | -2.5 |
| Purata | -1.63 |
|
OraSure Technologies Inc is a medical devices company that develops, manufactures, and distributes oral fluid diagnostic and collection devices. Its reportable segments are diagnostics and molecular solutions. The diagnostics segment produces rapid oral diagnostic tests and specimen collection devices for infectious diseases such as HIV and HCV. The molecular solutions segment specializes in kits used to collect, stabilize, and transport genetic material samples for molecular testing of both hereditary diseases and infectious diseases, such as COVID-19. The company gets majority of its sales from the molecular solutions business, derived mainly from customers in the United States. |
|
| Sektor | Healthcare |
| Industri | Medical Instruments & Supplies |
| Gaya Pelaburan | Small Core |
| % Dimiliki oleh Orang Dalam | 3.05% |
| % Dimiliki oleh Institusi | 91.53% |
Tiada data dalam julat masa ini.
Tiada data dalam julat masa ini.
| Tarikh | Jenis | Butiran |
|---|---|---|
| 19 Dec 2024 | Pengumuman | OraSure Technologies Acquires Sherlock Biosciences |
| 02 Dec 2024 | Pengumuman | OraSure Receives Federal Funding for Development of Marburg Virus Rapid Antigen Test |
| 18 Nov 2024 | Pengumuman | OraSure to Participate in Upcoming Investor Conference |
| 06 Nov 2024 | Pengumuman | OraSure Reports Q3 ’24 Revenue of $39.9 Million |
| 22 Oct 2024 | Pengumuman | OraSure to Announce Third Quarter 2024 Financial Results and Host Earnings Call on November 6th |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2024 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |